Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for nuclear receptor
Most Correlated Studies
- L1000 CMAP - Adenocarcinoma of breast MDAMB231 cells treated with ligand perturbagens
- L1000 CMAP - Breast cancer HS578T cells treated with ligand perturbagens
- Breast cancer MCF7 cells treated with nuclear receptor agonists
- L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
- L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
Most Relevant Literature
- Screening of Chelidonium majus isoquinoline alkaloids reveals berberine and chelidonine as selective…
- Opportunities and challenges in targeting orphan nuclear receptors.
- Nuclear receptor Rev-erbα role in fine-tuning erythropoietin gene expression.
- Control of Cell Identity by the Nuclear Receptor HNF4 in Organ Pathophysiology.
- The nuclear receptor REV-ERBα integrates circadian clock and energy metabolism.
Most Relevant Clinical Trials
- Development and Validation of in Vitro Cell-based Bioassays for Nuclear Receptor Activation
- Study of Genetic Polymorphisms of Drug Transporters and Orphan Nuclear Receptors on Treatment Effect…
- NASH and Type 2 Diabetes: Role of the Receptor Activator of Nuclear Factor-κB (RANK) and Its Ligand …
- Impact of the Rapid Normalization of Chronic Hyperglycemia and the Practice of Moderate Physical Act…
- Nuclear Myosin VI - a Therapeutic Target in Breast Cancer
